Heard in Brussels

More Articles


More Bio-People

  • M&A expertise for regmed

    19.12.2014 Gil Beyen has been appointed independent director of Belgian biotech Novadip Biosciences, a spin-off from Louvain... more

  • Turning commercial

    09.12.2014 Belgian Ablynx NV welcomed Johan Heylen as its new Chief Commercial Officer. The Flemish drug developer announced the... more

  • Head of Europe

    08.12.2014 Clinical stage biopharma firm Intercept Pharmaceuticals, focused on therapeutics to treat chronic liver and intestinal... more

  • Double appointments

    03.12.2014 Karus Therapeutics, a developer of medicines for the treatment of inflammatory diseases and cancer, has taken on two... more


More Articles

© 2007-2014 BIOCOM


Product of the week



All Events

Current issue

All issues